• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

英国青光眼诊所患者的视力丧失率是否会随着时间推移而放缓?十年数据的趋势。

Are rates of vision loss in patients in English glaucoma clinics slowing down over time? Trends from a decade of data.

作者信息

Boodhna T, Saunders L J, Crabb D P

机构信息

Optometry and Visual Science, School of Health Sciences, City University London, London, UK.

出版信息

Eye (Lond). 2015 Dec;29(12):1613-9. doi: 10.1038/eye.2015.161. Epub 2015 Aug 28.

DOI:10.1038/eye.2015.161
PMID:26315701
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5129813/
Abstract

PURPOSE

To examine changes in rates of visual field (VF) progression in patients attending a sample of glaucoma clinics in England between 1999 and 2012.

METHODS

An archive of 473 252 Humphrey VFs recorded across the UK was retrospectively examined. Distribution of rates recorded in the first half of the decade was compared with the second. The relationship between age and severity of MD loss at baseline with rates of loss and frequency of testing was examined.

RESULTS

VF series from 18 926 eyes were analysed. Median rate of MD loss for the period before and after 2003 was -0.11 and -0.06 dB/year, respectively, but the proportion of eyes with medium or fast rates of MD loss remained constant. Median rate of MD loss in older (>70 years) eyes was faster than that observed in younger (<60 years) eyes (-0.21 compared with -0.01 dB/year). Median rate of loss did not vary with severity of MD loss at baseline. Frequency of testing, typically carried out annually, did not vary by age, rate of loss or disease severity.

CONCLUSIONS

VFs of eyes treated in the first half of the decade deteriorated more rapidly than those in the second half. Several factors might explain these differences but average effects were small and there was no reduction in the proportion of rapidly progressing eyes over the decade. Older age and, to a lesser extent, worse VF damage at diagnosis are indicators for faster VF loss in clinics, but frequency of VF testing was similar for all patients.

摘要

目的

研究1999年至2012年间在英国部分青光眼诊所就诊的患者视野(VF)进展率的变化。

方法

对英国记录的473252份Humphrey视野进行回顾性研究。比较了该十年前半期和后半期记录的进展率分布情况。研究了基线时年龄与平均偏差(MD)损失严重程度与损失率和检测频率之间的关系。

结果

分析了18926只眼的视野系列。2003年前后期间MD损失的中位数率分别为-0.11和-0.06dB/年,但MD损失为中度或快速率的眼的比例保持不变。年龄较大(>70岁)的眼中MD损失的中位数率比年龄较小(<60岁)的眼更快(分别为-0.21和-0.01dB/年)。损失的中位数率在基线时不随MD损失的严重程度而变化。通常每年进行的检测频率不随年龄、损失率或疾病严重程度而变化。

结论

该十年前半期接受治疗的眼的视野比后半期恶化得更快。有几个因素可能解释这些差异,但平均影响较小,并且在这十年中快速进展眼的比例没有降低。年龄较大以及在较小程度上诊断时较差的视野损害是诊所中视野更快丧失的指标,但所有患者的视野检测频率相似。

相似文献

1
Are rates of vision loss in patients in English glaucoma clinics slowing down over time? Trends from a decade of data.英国青光眼诊所患者的视力丧失率是否会随着时间推移而放缓?十年数据的趋势。
Eye (Lond). 2015 Dec;29(12):1613-9. doi: 10.1038/eye.2015.161. Epub 2015 Aug 28.
2
Disease severity in newly diagnosed glaucoma patients with visual field loss: trends from more than a decade of data.初诊视野缺损青光眼患者的疾病严重程度:来自十多年数据的趋势
Ophthalmic Physiol Opt. 2015 Mar;35(2):225-30. doi: 10.1111/opo.12187. Epub 2014 Dec 29.
3
Effect of focal lamina cribrosa defect on glaucomatous visual field progression.视盘局限性筛板缺损对青光眼视野进展的影响。
Ophthalmology. 2014 Aug;121(8):1524-30. doi: 10.1016/j.ophtha.2014.02.017. Epub 2014 Mar 31.
4
Optic disc progression and rates of visual field change in treated glaucoma.治疗性青光眼的视盘进展和视野变化率。
Acta Ophthalmol. 2013 Mar;91(2):e86-91. doi: 10.1111/j.1755-3768.2012.02577.x. Epub 2013 Jan 29.
5
Factors affecting rates of visual field progression in glaucoma patients with optic disc hemorrhage.影响伴有视盘出血的青光眼患者视野进展速度的因素。
Ophthalmology. 2010 Jan;117(1):24-9. doi: 10.1016/j.ophtha.2009.06.028. Epub 2009 Nov 6.
6
Comparing glaucoma progression on 24-2 and 10-2 visual field examinations.比较24-2和10-2视野检查中的青光眼进展情况。
PLoS One. 2015 May 15;10(5):e0127233. doi: 10.1371/journal.pone.0127233. eCollection 2015.
7
Examining visual field loss in patients in glaucoma clinics during their predicted remaining lifetime.在青光眼门诊中检查患者在预计剩余寿命期间的视野丧失。
Invest Ophthalmol Vis Sci. 2014 Jan 7;55(1):102-9. doi: 10.1167/iovs.13-13006.
8
Portsmouth visual field database: an audit of glaucoma progression.朴茨茅斯视野数据库:青光眼病情进展的一项审计
Eye (Lond). 2014 Aug;28(8):974-9. doi: 10.1038/eye.2013.294. Epub 2014 May 30.
9
Relationship between severity of visual field loss at presentation and rate of visual field progression in glaucoma.视野丧失严重程度与青光眼视野进展速度的关系。
Ophthalmology. 2011 Feb;118(2):249-53. doi: 10.1016/j.ophtha.2010.05.027. Epub 2010 Aug 21.
10
Performance of the visual field index in glaucoma patients with moderately advanced visual field loss.视野指数在中度进展性视野损失的青光眼患者中的表现。
Am J Ophthalmol. 2014 Jan;157(1):39-43. doi: 10.1016/j.ajo.2013.09.003. Epub 2013 Nov 5.

引用本文的文献

1
Forecasting trends in glaucoma medication reimbursees in Finland: updated system dynamics model to 2070.芬兰青光眼药物报销趋势预测:至2070年的更新系统动力学模型
BMJ Open Ophthalmol. 2025 Aug 24;10(1):e002166. doi: 10.1136/bmjophth-2025-002166.
2
Prototype master protocol for benchmarking of real-world follow-up data in glaucoma.青光眼真实世界随访数据基准测试的原型主协议。
Acta Ophthalmol. 2025 Aug;103(5):539-551. doi: 10.1111/aos.17453. Epub 2025 Feb 13.
3
The value of virtual glaucoma clinics: a review.虚拟青光眼诊所的价值:综述。
Eye (Lond). 2024 Jul;38(10):1840-1844. doi: 10.1038/s41433-024-03056-7. Epub 2024 Apr 8.
4
Prevalence of Glu323Lys Mutation of the Gene and Risk Factors amongst Primary Open-angle Glaucoma Patients in Ouagadougou, Burkina Faso.布基纳法索瓦加杜古原发性开角型青光眼患者中该基因Glu323Lys突变的患病率及危险因素
J Curr Glaucoma Pract. 2023 Apr-Jun;17(2):79-84. doi: 10.5005/jp-journals-10078-1403.
5
Measures of multiple deprivation and visual field loss in glaucoma clinics in England: lessons from big data.英国青光眼诊所的多种剥夺措施与视野缺失:大数据带来的启示。
Eye (Lond). 2023 Dec;37(17):3615-3620. doi: 10.1038/s41433-023-02567-z. Epub 2023 May 10.
6
Clinical risk stratification in glaucoma.青光眼的临床风险分层。
Eye (Lond). 2023 Oct;37(15):3121-3127. doi: 10.1038/s41433-023-02480-5. Epub 2023 Mar 14.
7
24-Hour Monitoring of Intraocular Pressure Fluctuations Using a Contact Lens Sensor: Diagnostic Performance for Glaucoma Progression.使用接触镜传感器 24 小时监测眼压波动:青光眼进展的诊断性能。
Invest Ophthalmol Vis Sci. 2023 Mar 1;64(3):3. doi: 10.1167/iovs.64.3.3.
8
Fast Progressors in Glaucoma: Prevalence Based on Global and Central Visual Field Loss.青光眼快速进展者:基于全球和中央视野损失的患病率。
Ophthalmology. 2023 May;130(5):462-468. doi: 10.1016/j.ophtha.2023.01.008. Epub 2023 Jan 21.
9
Effect of Testing Frequency on the Time to Detect Glaucoma Progression With Optical Coherence Tomography (OCT) and OCT Angiography.检测频率对使用光学相干断层扫描(OCT)和OCT血管造影术检测青光眼进展时间的影响。
Am J Ophthalmol. 2023 Jan;245:184-192. doi: 10.1016/j.ajo.2022.08.030. Epub 2022 Sep 10.
10
Functional assessment of glaucoma: Uncovering progression.青光眼的功能评估:揭示进展。
Surv Ophthalmol. 2020 Nov-Dec;65(6):639-661. doi: 10.1016/j.survophthal.2020.04.004. Epub 2020 Apr 26.

本文引用的文献

1
The cost-effectiveness of initiating ranibizumab therapy in eyes with neovascular AMD with good vision: an economic model using real-world outcomes.在视力良好的新生血管性年龄相关性黄斑变性(neovascular AMD)眼中启动雷珠单抗治疗的成本效益:一项使用真实世界结果的经济模型。
BMJ Open. 2015 May 5;5(5):e006535. doi: 10.1136/bmjopen-2014-006535.
2
Disease severity in newly diagnosed glaucoma patients with visual field loss: trends from more than a decade of data.初诊视野缺损青光眼患者的疾病严重程度:来自十多年数据的趋势
Ophthalmic Physiol Opt. 2015 Mar;35(2):225-30. doi: 10.1111/opo.12187. Epub 2014 Dec 29.
3
Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial.拉坦前列素治疗开角型青光眼(英国青光眼治疗研究组):一项随机、多中心、安慰剂对照试验。
Lancet. 2015 Apr 4;385(9975):1295-304. doi: 10.1016/S0140-6736(14)62111-5. Epub 2014 Dec 19.
4
Rates of glaucomatous visual field change in a large clinical population.大临床人群中青光眼视野变化的速率。
Invest Ophthalmol Vis Sci. 2014 Jun 10;55(7):4135-43. doi: 10.1167/iovs.14-14643.
5
The neovascular age-related macular degeneration database: multicenter study of 92 976 ranibizumab injections: report 1: visual acuity.新生血管性年龄相关性黄斑变性数据库:92976 例雷珠单抗注射的多中心研究:报告 1:视力。
Ophthalmology. 2014 May;121(5):1092-101. doi: 10.1016/j.ophtha.2013.11.031. Epub 2014 Jan 23.
6
A qualitative investigation into patients' views on visual field testing for glaucoma monitoring.一项关于患者对青光眼监测视野测试看法的定性调查。
BMJ Open. 2014 Jan 10;4(1):e003996. doi: 10.1136/bmjopen-2013-003996.
7
Clinical utilization of anti-VEGF agents and disease monitoring in neovascular age-related macular degeneration.抗血管内皮生长因子药物的临床应用及新生血管性年龄相关性黄斑变性的疾病监测。
Am J Ophthalmol. 2014 Apr;157(4):825-833.e1. doi: 10.1016/j.ajo.2013.12.018. Epub 2013 Dec 31.
8
Examining visual field loss in patients in glaucoma clinics during their predicted remaining lifetime.在青光眼门诊中检查患者在预计剩余寿命期间的视野丧失。
Invest Ophthalmol Vis Sci. 2014 Jan 7;55(1):102-9. doi: 10.1167/iovs.13-13006.
9
United Kingdom National Ophthalmology Database Study: Diabetic Retinopathy; Report 1: prevalence of centre-involving diabetic macular oedema and other grades of maculopathy and retinopathy in hospital eye services.英国国家眼科数据库研究:糖尿病视网膜病变;报告 1:医院眼科服务中中心性糖尿病性黄斑水肿和其他黄斑病变及视网膜病变的患病率。
Eye (Lond). 2013 Dec;27(12):1397-404. doi: 10.1038/eye.2013.196. Epub 2013 Sep 20.
10
A survey of attitudes of glaucoma subspecialists in England and Wales to visual field test intervals in relation to NICE guidelines.一项针对英格兰和威尔士青光眼专家对与 NICE 指南相关的视野检查间隔时间的态度的调查。
BMJ Open. 2013 May 3;3(5):e002067. doi: 10.1136/bmjopen-2012-002067.